These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

472 related items for PubMed ID: 10644793

  • 1. Novel presenilin-1 mutation with widespread cortical amyloid deposition but limited cerebral amyloid angiopathy.
    Yasuda M, Maeda S, Kawamata T, Tamaoka A, Yamamoto Y, Kuroda S, Maeda K, Tanaka C.
    J Neurol Neurosurg Psychiatry; 2000 Feb; 68(2):220-3. PubMed ID: 10644793
    [Abstract] [Full Text] [Related]

  • 2. A pathogenic presenilin-1 deletion causes abberrant Abeta 42 production in the absence of congophilic amyloid plaques.
    Steiner H, Revesz T, Neumann M, Romig H, Grim MG, Pesold B, Kretzschmar HA, Hardy J, Holton JL, Baumeister R, Houlden H, Haass C.
    J Biol Chem; 2001 Mar 09; 276(10):7233-9. PubMed ID: 11084029
    [Abstract] [Full Text] [Related]

  • 3. The impact of different presenilin 1 andpresenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain: evidence for other phenotype-modifying factors.
    Gómez-Isla T, Growdon WB, McNamara MJ, Nochlin D, Bird TD, Arango JC, Lopera F, Kosik KS, Lantos PL, Cairns NJ, Hyman BT.
    Brain; 1999 Sep 09; 122 ( Pt 9)():1709-19. PubMed ID: 10468510
    [Abstract] [Full Text] [Related]

  • 4. Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease.
    Mann DM, Pickering-Brown SM, Takeuchi A, Iwatsubo T, Members of the Familial Alzheimer's Disease Pathology Study Group.
    Am J Pathol; 2001 Jun 09; 158(6):2165-75. PubMed ID: 11395394
    [Abstract] [Full Text] [Related]

  • 5. Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele.
    Vidal R, Calero M, Piccardo P, Farlow MR, Unverzagt FW, Méndez E, Jiménez-Huete A, Beavis R, Gallo G, Gomez-Tortosa E, Ghiso J, Hyman BT, Frangione B, Ghetti B.
    Acta Neuropathol; 2000 Jul 09; 100(1):1-12. PubMed ID: 10912914
    [Abstract] [Full Text] [Related]

  • 6. ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice.
    Button EB, Boyce GK, Wilkinson A, Stukas S, Hayat A, Fan J, Wadsworth BJ, Robert J, Martens KM, Wellington CL.
    Alzheimers Res Ther; 2019 May 13; 11(1):44. PubMed ID: 31084613
    [Abstract] [Full Text] [Related]

  • 7. Amyloid angiopathy in a Volga German family with Alzheimer's disease and a presenilin-2 mutation (N141I).
    Nochlin D, Bird TD, Nemens EJ, Ball MJ, Sumi SM.
    Ann Neurol; 1998 Jan 13; 43(1):131-5. PubMed ID: 9450781
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cerebral amyloid angiopathy and dementia.
    Tian J, Shi J, Mann DM.
    Panminerva Med; 2004 Dec 13; 46(4):253-64. PubMed ID: 15876981
    [Abstract] [Full Text] [Related]

  • 13. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.
    Lue LF, Kuo YM, Roher AE, Brachova L, Shen Y, Sue L, Beach T, Kurth JH, Rydel RE, Rogers J.
    Am J Pathol; 1999 Sep 13; 155(3):853-62. PubMed ID: 10487842
    [Abstract] [Full Text] [Related]

  • 14. Amyloid-β peptide signature associated with cerebral amyloid angiopathy in familial Alzheimer's disease with APPdup and Down syndrome.
    Kasri A, Camporesi E, Gkanatsiou E, Boluda S, Brinkmalm G, Stimmer L, Ge J, Hanrieder J, Villain N, Duyckaerts C, Vermeiren Y, Pape SE, Nicolas G, Laquerrière A, De Deyn PP, Wallon D, Blennow K, Strydom A, Zetterberg H, Potier MC.
    Acta Neuropathol; 2024 Jul 18; 148(1):8. PubMed ID: 39026031
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Distinguishable effects of presenilin-1 and APP717 mutations on amyloid plaque deposition.
    Ishii K, Lippa C, Tomiyama T, Miyatake F, Ozawa K, Tamaoka A, Hasegawa T, Fraser PE, Shoji S, Nee LE, Pollen DA, St George-Hyslop PH, Ii K, Ohtake T, Kalaria RN, Rossor MN, Lantos PL, Cairns NJ, Farrer LA, Mori H.
    Neurobiol Aging; 2001 Jul 18; 22(3):367-76. PubMed ID: 11378241
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons.
    Van Dorpe J, Smeijers L, Dewachter I, Nuyens D, Spittaels K, Van Den Haute C, Mercken M, Moechars D, Laenen I, Kuiperi C, Bruynseels K, Tesseur I, Loos R, Vanderstichele H, Checler F, Sciot R, Van Leuven F.
    Am J Pathol; 2000 Oct 18; 157(4):1283-98. PubMed ID: 11021833
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.